Studies have found that the hub regions in AD patients are more likely to deposit β‐amyloid (Crossley et al., 2014; Scheinin et al., 2009; Zhou et al., 2012), and insulin resistance can accelerate this process (Verdile et al., 2015). Here, INS is linked to Alzheimer disease.